And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

The CBSE Class 10 exams will take place between February 17 and March 10, and the Class 12 exams will be conducted from ...

Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q3, 2025 Earnings Conference Call.

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential ...

“During our third quarter of 2025, we continued to position the Company to advance IKT-001 toward a late-stage clinical trial in PAH,” said Mark Iwicki, Chief Executive Officer of Inhibikase. “We ...

Scholar Rock Holding Corporation ( SRRK) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to Scholar Rock's Third Quarter 2025 Conference Call.

The UAE’s mall economy is booming with new developments opening up and the existing icons undergoing a makeover. Is the growth sustainable?

Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced ...

They call it the quiet storm—the kind of powder silence that arrives after a storm so perfect it seems conspiratorial.

Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to Novel Opioid Solutions ~ ~ Further Program Advancement Supported by ...

These papers help students understand the latest exam pattern, important question types, chapter-wise weightage, and ...